Context Therapeutics
CNTX
CNTX
25 hedge funds and large institutions have $5.43M invested in Context Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.36% more ownership
Funds ownership: 22.28% → 24.64% (+2.4%)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$284K | |
| 2 | +$184K | |
| 3 | +$30.9K | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$15.8K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$14.2K |
Top Sellers
| 1 | -$11.3K | |
| 2 | -$10.7K | |
| 3 | -$1.16K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$411 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$123 |